Acorda Therapeutics Inc (ACORQ): 6:46AM Acorda Therapeutics announces pri...

Reply Private New

Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore

Followers	466
Posts	26934
Boards Moderated	2
Alias Born	09/11/2006

surf1944

Re: None

Wednesday, 02/03/2010 8:42:38 AM

Wednesday, February 03, 2010 8:42:38 AM

6:46AM Acorda Therapeutics announces pricing and patient assistance programs for AMPYRA (dalfampridine) (ACOR) 30.42 : Co announces the wholesale acquisition cost for AMPYRA (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the FDA as a treatment to improve walking in patients with multiple sclerosis. This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.

surf's up......crikey

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ACORQ News

Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:44:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:40:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 12:24:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:24:14 PM